Abstract
Members of adenoviral family represent middle-sized viruses composed of a complex protein capsid and a linear double-stranded DNA of molecular weight 20–22 mD or 35–36 kb coding for about 30 virion and virus-specific proteins. The ends of adenoviral genome have inverted terminal repeats 100–200 nucleotide long, each of which contains identical replication origins. These sites represent the cis-acting element indispensable in any virus vector construction. The second cis-element of adenoviral genome absolutely necessary in the capsid type of viral vectors is the package signal located in the left noncodig part of the DNA molecule 200–300 nucleotides long between the terminal repeat and the El cistron (Doerfler, 1983/1984; Ginsberg, 1984).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berencsi G. & Nasz I., 1983, Adenoviruses and human tumors: regulation of eukaryotic chromatin structure, Arch.Geschwulstforsch. 53:239.
Berkner K. L. & Sharp P.A., 1982, Preperation of adenovirus recombinants using plasmid of viral DNA, in “Eukaryotic viral vectors”, Y.Gluzman, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor.
Berkner K. L. & Sharp P. A., 1985, Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant, Nucl. Acid Res., 13:841.
Berkner K. L., Schaffhausen B., Roberts T. M. & Sharp P. A., 1987, Abundant expression of polyomavirus T antigen and dihydrofolate reductase in an adenovirus recombinant, J. Virol., 61:1213.
Bhat B. M. & Wold W.S.M., 1986, Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants, J. Virol., 60:54.
Borelli E., Hen R. & Chambon P., 1984, Adenovirus2 E1A products repress SV40 enhancer induced stimulation of transcription, Nature, 312:608.
Chinandurai G., 1983, Adenovirus 21p+ locus codes for a 19 kD tumor antigen that plays an essential role in cell transformation, Cell, 33:759.
Davidson D. & Hassel J. A., 1987, Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector, J. Virol., 61:1226.
Davis A. R., & Huang P. P., 1987, Oral vaccines, European Patent Application EP 0181117.
Davis A. R., Kostek B., Mason B. B., Hsiao C. L., Morin J., Barton J., Dheer S. K., Zandler G. & Huang P. P., 1986, Expression of hepatitis B surface antigen with a recombinant adenovirus, in “Vaccines 86”, Cold Spring Harbor Laboratory, Cold Spring Harbor.
Davis A. R., Kostek B., Mason B. B., Hsiao C. L.,. Morin J., Dheer S. K. & Huang P. P., 1985, Expression of hepatitis B surface antigen with a recombinant adenovirus, Proc. Nat. Acad. Sci. USA, 82:7560.
Doerfler W., ed., 1983/1984, “The molecular biology of adenoviruses”, Curr. Topics Microbiol. and Immunology, v.109, 110, 111, Springer Verlag, W.Berlin.
Dudding B. A., Top F. H., Scott R. M., Russell P. K. & Buescher E. L., 1972, An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines, Amer. J. Epidimiol., 95:140.
Fucui Y., Saito I., Shiroke K. & Shimojo H., 1984, Isolation of trans-forming-defective replication-nondefective early region 1B mutants of adenovirus 12, J.Virol., 44:154.
Ghosh-Choudhury G. & Graham F. L., 1987, Stable transfer of mouse dihydrofolate reductase gene into a deficient cell line using human adenovirus vector, Bioch. Biophys. Res. Commun., 147:964.
Ghosh-Choudhury G., Haj-Ahmad Y. & Graham F. L.,1987, Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full-length genomes, The EMBO J.,6,:1733.
Ginsberg H. S., ed.“ The adenoviruses”, Plenum Press, New York.
Gluzman Y., Reichl H. & Solnick D., 1982, Helper-free adenovirus type 5 vectors, in “Eukaryotic viral vectors” Y.Gluzman, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor.
Graham F. L., 1984, Transformation by and oncogenecity of human adenoviruses, in “Adenoviruses”, H.S.Ginsberg, ed., Plenum Press, New York.
Graham F. L., Smiley J., Russel W. C, & Nairn R., 1977, Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. Virol., 36:59.
Green M. & Mackey J., 1977, Are oncogenic adenoviruses associated with human cancer? Analysis of human tumors for adenovirus transforming gene sequences, Cold Spring Harbor Conferences of Cell Prolifera-tion, v.4:1027.
Green M., Wold W. & Mackey J., 1979, Analysis of human tonsil and cancer DNAs and RNAs for sequences of group C human adenoviruses, Proc. Nat. Acad. Sci. USA, 76:6606.
Haj-Ahmad Y. & Graham F. L., 1986, Development of a helper- independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene, J. Virol., 57:267.
Hay R. T. & McDougall I. M., 1986, Viable viruses with deletions in the left inverted terminal repeat define the adenovirus origin of DNA replication, J. gen. Virol., 67:321.
Jones N. & Shenk T., 1987, Isolation of deletion and substitution mutants of adenovirus type 5, Cell, 13:181.
Jones L., Ristow S., Yilma T. & Moss B., 1986, Accidental human vaccination with vaccinia virus expressing nucleoprotein gene, Nature, 319:543.
Jonson D. C., Ghosh-Choudhury G., Smiley J. R., Fallis L & Graham F. L., 1988, Abundant expression of herpes simplex virus glyco-protein gB using an adenovirus vector, Virology, 164:1.
Ibelgaufts H. 1982, Are human DNA tumor viruses involved in the pathogenesis of human neurogenetic tumors, Neurosurg. Rew., 5:3.
Karlsson S., Humphries R. K., Gluzman Y. & Nienhuis A. W., 1985, Transfer of genes into hematopoetic cells using recombinant DNA viruses, Proc. Nat. Acad. Sci. USA, 82:158.
Katze M. G., Chen Y. T. & Krug R. M., 1981, Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells, Cell, 37:483.
Kaufman R. J., 1985, Identification of the component necessary for adenovirus translational control and their utilization in cDNA expression vectors, Proc. Nat. Acad. Sci. USA, 82:689.
Klessig D. F., 1984, Adenovirus-SV40 interactions, in “Adenoviruses” H. S. Ginsberg, ed., Plenum Press, New York.
Logan J. & Pilder S., 1985, The use of adenovirus recombinants to study viral gene expression, in “Genetically altered viruses”, B.Fields, M.A.Martins & D.Kamely, eds., Cold Spring Harbor Laboratory, Cold Spring Harbor.
Mackey J., Green M., Wold W. & Rigden P., 1979, Analysis of human cancer DNA sequences for DNA of human adenovi ruses type 4, J. Nat. Cancer Inst. 62:23.
Mackey J. K., Rigden P. & Green M., 1976, Do highly oncogenic group A human adenoviruses cause human cancer? Analysis of human tumors for adenovirus 12 transforming DNA segments, Proc. Nat. Acad. Sci. USA, 73:4657.
Mansour S. L., Grodzicker T. & Tjian R., 1985, An adenovirus vector system used to express polyomavirus tumor antigenes, Proc. Nat. Acad. Sci. USA, 82:1359.
Meiklejohn G., 1983, Viral respiratory disease at Lowrey Air Force Base in Denver, 1952–1982, J. Infect. Dis., 148:775.
Morin J. E.,Lubeck M. D., Barton J. E., Conley A. J. & Davis A, R., 1987, Recombinant adenovirus induces antibody responce to hepatitis B virus surface antigen in hamsters, Proc. Nat. Acad. Sci. USA, 84:4626.
Naroditsky B. S., Miroshnichenko O .I., Ponomareva T. I. & Tikchonenko T. I., 1983, Construction of the eukaryotic vector using adenovirus type 1, Mol. Genet. Microbiol., Virology, 12:28 (in Russian).
Naroditsky B. S., Miroshnichenko O .I., Ponomareva T. I. & Tikchonenko T. I., 1986, Expression of hepatitis B virus gene inserted into recombinant adenovirus, Mol. Genet. Microbiol., Virology, 1:42 (in Russian).
Roizman B. & Jenkins F. J., 1985, Genetic engineering of novel genomes of large DNA viruses, Science, 229:1208.
Saito I., Qya Y., Yamamoto K., Yuasa T. & Shimojo H., 1985, Construe- tion of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome, J. Virol., 54:711.
Shenk T. & Williams J., 1984, Genetic analysis of adenoviruses, Curr. Topics Microbiol. and Immunol., 111:1.
Struk V. I., Tikchonenko T. I. & Sovzova Z. D., 1987, “Infectious viruses and cancerogenesis”, Publ. House “Naukova Dumka”, Kiev (in Russian).
Takafuji E. T., Gaydos J. C., Allan R. G. & Top F. H., 1979, Simultaneous administration of live enteric-coated adenovirus type 4,7 and 21 vaccines: safety and immunochemistry, J. Infect. Dis., 140:48.
Tikchonenko T. I., 1985, Construction of eukaryotic vectors, Biotech-nol., 2:24 (in Russian).
Tiollais P., Charney P. & Vias G. N., 1981, Biology of hepatitis B virus, Science, 213:406.
Thummel C., Tjian R. & Grodziker T., 1981, Expression of SV40 large T antigen under control of Ad promoter, Cell, 23:825.
van der Eb A. J., & Bernards R., 1984, Transformation and oncogenicity by adenoviruses, Curr. Topics Microbiol. and Immunol., 110:23.
van Doren K., Hanahan D. & Gluzman Y., 1984, Infection of eucaryotic cells by helper independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA, J. Virol., 50:606.
Velcich A. & Ziff E., 1985, Adenovirus E1A proteins repress transcription from SV40 early promoter, Cell, 40:705.
Yarnada M., Lewis J. A. & Grodzicker T., 1985, Overproduction of the protein product of a non-selected foreign gene carried by an adenovirus vector, Proc. Nat. Acad. Aci. USA, 82:3567.
Young C. S., Shenk T. & Ginsberg H. S., 1984/ The genetic system, in “Adenoviruses”, H.S.Ginsberg, ed., Plenum Press, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this paper
Cite this paper
Tikchonenko, T.I. (1989). Adenoviruses as Vectors for the Transfer of Genetic Information and for the Construction of New Type Vaccines. In: Askonas, B.A., Moss, B., Torrigiani, G., Gorini, S. (eds) The Immune Response to Viral Infections. Advances in Experimental Medicine and Biology, vol 257. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5712-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5712-4_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5714-8
Online ISBN: 978-1-4684-5712-4
eBook Packages: Springer Book Archive